Shares in biotech company Recursion Pharmaceuticals ( RXRX 12.07%) surged by more than 12% by 11 a.m. ET today. The move is ...

Recursion Pharmaceuticals bounced back by 8.72 percent on Tuesday to close at $5.36 apiece following news that it acquired a ...

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

Recursion Pharmaceuticals , Inc. (NASDAQ: RXRX), currently trading at $5.11 after declining over 10% in the past week, announced the results of its 2025 annual meeting of stockholders held on ...

Read about Recursion Pharmaceuticals Inc Class A (RXRX:XNAS) stock and today's latest news and financial updates.

Check out our RXRX stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Morgan Stanley assumed coverage of the company’s stock with an “Equal ...

Find the latest on short interest, settlement dates, average share volume, and days to cover for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com.

It’s been just over ten years since the Vancouver Canucks drafted Brock Boeser at 23rd overall of the 2015 NHL Entry Draft.

UM-CPP rapidly determines the presence of protein particles within the field of view, allowing subsequent detection efforts to be more focused and efficient. Specifically, UM-CPP provides an initial ...